Summary of Significant Accounting Policies Summary of Significant Accounting Principles (Tables)

12 Months Ended

Jun. 30, 2026

Schedule of Other Nonoperating Income (Expense)

Other Income (Expense), Net

The following table summarizes the components of other income (expense), net.


	Year Ended June 30,
	2026		2025		2024
Gains (losses) on derivatives not designated as hedging instruments (1)	$	21,935	$	(35,027)	$	3,915
Currency-related (losses) gains, net (2)	(12,935)		21,090		(2,818)
Other gains	2,340		355		486
Total other income (expense), net	$	11,340	$	(13,582)	$	1,583

_____________________

(1) Includes realized and unrealized gains and losses on derivative currency forward and option contracts not designated as hedging instruments, as well as the ineffective portion of certain interest rate swap contracts that have been de-designated from hedge accounting. For contracts not designated as hedging instruments, we realized (losses) gains of ($14,169), $2,706 and $(1,078), respectively, for the fiscal years ended June 30, 2026, 2025, and 2024. Refer to Note 4 for additional details relating to our derivative contracts.

(2) Currency-related (losses) gains, net primarily relates to significant non-functional currency intercompany financing relationships that we may change at times and are subject to currency exchange rate volatility. In addition, during all fiscal years presented, we had certain cross-currency swaps designated as cash flow hedges, which hedge the remeasurement of certain intercompany loans; refer to Note 4 for additional details relating to these cash flow hedges.

Schedule of Weighted Average Number of Shares

The following table sets forth the reconciliation of the weighted-average number of ordinary shares.


	Year Ended June 30,
		2026	2025	2024
Weighted average shares outstanding, basic		24,425,018	24,923,797	26,151,968
Weighted average shares issuable upon exercise/vesting of outstanding share options/RSUs/PSUs/warrants (1)		901,596	713,068	852,719
Shares used in computing diluted net income per share attributable to Cimpress plc		25,326,614	25,636,865	27,004,687
Weighted average anti-dilutive shares excluded from diluted net income per share attributable to Cimpress plc (1)		729,928	1,001,612	96,207

___________________

(1) On May 1, 2020, we entered into a financing arrangement, which included 7-year warrants to purchase 1,055,377 of our ordinary shares with a strike price of $60. The effect of the warrants on our weighted-average shares outstanding for a period is dilutive if the average market price of our ordinary shares during the period was higher than the strike price of the warrants and anti-dilutive if the average market price of our ordinary shares during the period was lower than the strike price of the warrants.